MARKET

FHTX

FHTX

Foghorn Therapeutics Inc.
NASDAQ
2.050
+0.050
+2.50%
After Hours: 2.050 0 0.00% 19:30 10/26 EDT
OPEN
1.990
PREV CLOSE
2.000
HIGH
2.060
LOW
1.930
VOLUME
509.75K
TURNOVER
--
52 WEEK HIGH
7.61
52 WEEK LOW
1.790
MARKET CAP
121.74M
P/E (TTM)
-2.0863
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FHTX last week (1012-1016)?
Weekly Report · 10/19 09:36
Foghorn Therapeutics downgraded to In Line from Outperform at Evercore ISI
TipRanks · 10/13 09:20
Weekly Report: what happened at FHTX last week (1005-1009)?
Weekly Report · 10/12 09:39
FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law
Barchart · 10/11 16:16
Foghorn: Downgrade 'Sell' Eli Lilly Exit FHD-909 And Shift To Preclinical Assets
Seeking Alpha · 10/06 12:32
Weekly Report: what happened at FHTX last week (0928-1002)?
Weekly Report · 10/05 09:38
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 10/02 17:05
Foghorn Therapeutics Cut to Neutral From Outperform by Wedbush
Dow Jones · 10/02 14:55
More
About FHTX
Foghorn Therapeutics Inc. is a clinical-stage, precision therapeutics biotechnology company. The Company is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control platform, it is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is also developing multiple product candidates in oncology. The Gene Traffic Control platform provides an integrated and mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing to identify, validate and potentially drug targets within this system. Its platform enables to produce components of the chromatin regulatory system at scale, thereby allowing to identify these genetic dependencies, understand their mechanism and target their vulnerabilities.

Webull offers Foghorn Therapeutics Inc stock information, including NASDAQ: FHTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FHTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FHTX stock methods without spending real money on the virtual paper trading platform.